Regeneron Pharmaceuticals (REGN)

Investing Cash Flow

-$92.70M

Quarterly · Period ending: · USD

REGN logo

REGN Investing Cash Flow

Latest reported-$92.70M
REGN Quarterly Cash from Investing (-$1.50M → -$92.70M)
High-resolution chart · PNG

REGN investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-92,700,000
-428,900,000
220,300,000
-402,900,000
-1,094,000,000
647,500,000
350,600,000
-574,400,000
-557,200,000
-1,687,100,000
-66,200,000
-496,300,000
-2,386,900,000
-235,700,000
-1,857,700,000
192,300,000
-413,900,000
-1,705,300,000
-2,012,700,000
-2,438,800,000
125,800,000
-1,059,000,000
-305,000,000
-775,800,000
1,453,400,000
-443,200,000
-208,700,000
-207,000,000
-836,000,000
-776,100,000
-265,907,000
-286,708,000
-484,973,000
-425,412,000
-335,746,000
-358,884,000
-170,409,000
-140,143,000
-271,356,000
-405,853,000
-326,010,000
-43,685,000
-123,300,000
-283,171,000
-371,649,000
-129,481,000
56,645,000
-123,068,000
-118,123,000
-236,231,000
-109,948,000
-214,452,000
116,630,000
-147,685,000
91,103,000
-48,754,000
-139,188,000
15,766,000
-33,908,000
-903,000
142,935,000
20,347,000
-353,774,000
51,004,000
4,595,000
-135,978,000
-19,170,000
-13,471,000
72,325,000
-39,538,000
84,671,000
62,777,000
-154,577,000
37,944,000
36,463,000
-1,874,000
-46,200,000
-74,112,000
-163,214,000
66,463,000
-47,484,000
-10,870,000
25,303,000
45,800,000
25,966,000
18,425,000
7,567,000
-13,392,000
-68,988,000
70,230,000
-156,491,000
57,625,000
-26,796,000
61,819,000
34,935,000
30,102,000
-36,626,000
-86,927,000
-26,207,000
-21,488,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.